BIOL:NSD-BIOLASE, Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 0.28

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

1.10M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems to perform soft tissue, hygiene, cosmetic procedures, and teeth whitening, as well as to provide temporary pain relief; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California. Address: 4 Cromwell, Irvine, CA, United States, 92618

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-26 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

N/A

USD25.05B 14.49 68.43
PODD Insulet Corporation

N/A

USD14.70B 773.39 143.86
LVGO Livongo Health, Inc

N/A

USD13.69B N/A N/A
ABMD Abiomed, Inc

N/A

USD12.00B 75.42 46.69
TNDM Tandem Diabetes Care, Inc

N/A

USD6.60B N/A N/A
BRKR Bruker Corporation

N/A

USD5.99B 36.51 18.69
SDC SmileDirectClub, Inc

N/A

USD3.99B N/A N/A
IART Integra LifeSciences Holdings ..

N/A

USD3.96B 160.06 27.46
WMGI Wright Medical Group N.V

N/A

USD3.95B N/A 62.99
NUVA NuVasive, Inc

N/A

USD2.56B 49.69 17.19

ETFs Containing BIOL

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -49.09% 20% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -49.09% 20% F 11% F
Trailing 12 Months  
Capital Gain -71.13% 7% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -71.13% 7% F 4% F
Trailing 5 Years  
Capital Gain -93.78% 20% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -93.78% 20% F 5% F
Average Annual (5 Year Horizon)  
Capital Gain -28.98% N/A N/A 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -28.98% N/A N/A 5% F
Risk Return Profile  
Volatility (Standard Deviation) 52.48% N/A N/A 21% F
Risk Adjusted Return -55.23% N/A N/A 13% F
Market Capitalization 0.03B 20% F 12% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 20.11 13% F 5% F
Price / Cash Flow Ratio -2.03 46% F 66% D
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -774.75% 5% F 1% F
Return on Invested Capital -87.10% 28% F 11% F
Return on Assets -35.87% 24% F 10% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 0.09 95% A 95% A
Short Percent 0.65% 95% A 86% B
Beta 1.94 13% F 15% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector